A Rhetorical Exploration of Barriers to U.S. Biosimilar Uptake
Electronic Theses and Dissertations
Item Files
Item Details
- abstract
- Utilizing an Ethos as a Location and Rhetorical Ecology framework, this thesis discusses the ecology of the public discourse of the U.S. biosimilar market, specifically how certain aspects of the U.S. biosimilar environment contribute to various stakeholders’ understanding of biosimilars. Through an analysis of historical events involving generic drugs, traditional legal tactics intended to delay market entry of generic drugs and biosimilars, regulatory policies and the role of biosimilars within the drug pricing policy discourse in Washington DC, we can better understand how biosimilar education and uptake is manage by the current discourse.
- subject
- Biosimilars
- FDA
- Generic Drugs
- Pharmaceuticals
- Regulatory
- Rhetorical Ecology
- contributor
- Von Burg, Ron (committee chair)
- Canzona, Mollie (committee member)
- Feldman, Steven (committee member)
- date
- 2020-05-29T08:36:14Z (accessioned)
- 2020-05-29T08:36:14Z (available)
- 2020 (issued)
- degree
- Communication (discipline)
- identifier
- http://hdl.handle.net/10339/96864 (uri)
- language
- en (iso)
- publisher
- Wake Forest University
- title
- A Rhetorical Exploration of Barriers to U.S. Biosimilar Uptake
- type
- Thesis